Rice Hall James & Associates’s Viemed Healthcare VMD Stock Holding History

Rice Hall James & Associates’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.38M	Sell	209,066 -21,316	-9%	-$211K	0.12%	163
2026 Q1	$2.12M	Hold	230,382	–	–	0.12%	159
2025 Q4	$1.71M	Buy	230,382 +30,981	+16%	+$212K	0.09%	172
2025 Q3	$1.35M	Sell	199,401 -39,672	-17%	-$269K	0.07%	188
2025 Q2	$1.65M	Sell	239,073 -21,126	-8%	-$143K	0.09%	176
2025 Q1	$1.89M	Buy	260,199 +415	+0.2%	+$3.26K	0.11%	164
2024 Q4	$2.08M	Buy	+259,784	New	+$2.25M	0.11%	173
2022 Q1	–	Sell	-376,602	Closed	-$1.97M	–	320
2021 Q4	$1.97M	Sell	376,602 -57,803	-13%	-$323K	0.07%	213
2021 Q3	$2.41M	Sell	434,405 -94,494	-18%	-$615K	0.09%	176
2021 Q2	$3.78M	Buy	528,899 +79,065	+18%	+$685K	0.13%	116
2021 Q1	$4.55M	Buy	+449,834	New	+$4.23M	0.15%	118

Other funds holding VMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Rice Hall James & Associates's VMD Position: Q2 2026 in Review

Rice Hall James & Associates reduced its Viemed Healthcare (VMD) stake by 9.3% in Q2 2026, selling an estimated $211K and leaving 209,066 shares worth $2.38M. The position accounts for 0.12% of the portfolio, ranked #163.

Rice Hall James & Associates first reported a position in VMD in Q1 2021 and has held it in 11 quarters since. The position peaked at $4.55M in Q1 2021. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

Rice Hall James & Associates held 209,066 shares of Viemed Healthcare worth $2.38M as of Q2 2026.
Rice Hall James & Associates sold 21,316 Viemed Healthcare shares in Q2 2026, an estimated $211K.
Viemed Healthcare made up 0.12% of Rice Hall James & Associates's portfolio in Q2 2026, its #163 holding.
Rice Hall James & Associates first reported a position in Viemed Healthcare in Q1 2021 and has held it in 11 quarters since.
Rice Hall James & Associates's Viemed Healthcare position peaked at $4.55M in Q1 2021.
166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.